Healthcare

PRODUCTS

  • GettyImages-2161842577-business-professional-laptop-office-table
    Medical Writing Software

    Accelerate Medical Writing Without Compromising Accuracy or Compliance

    In the fast-paced world of clinical research, the ability to produce, review, and finalize high-quality documents—on time and with full regulatory compliance—is non-negotiable. Ideagen Document Review (formerly known as PleaseReview) is the trusted collaboration and co-authoring platform that enables clinical teams to streamline document reviews, reduce version chaos, and ensure traceable, auditable feedback across the board.

  • GettImages- 1217466412 data
    Study Design In Fountayn: Build Your Own Adventure

    Discover how Fountayn’s Study Team supports clinical teams from the trial build and startup, administration, training, and design changes to data archiving and closing procedures.

  • GettyImages-1414481878 clinical trial, patient, diversity
    How Trial Compass Is Solving Psychiatric Trial Enrollment

    Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:

    • Narrow I/E criteria that don’t translate into real-world patients
    • Sites with limited behavioral health infrastructure
    • Lack of patient trust and trial awareness in psychiatric populations
    • Professional patients
    • Rating scales aren’t used in clinical practices

    But what if recruitment didn’t have to start with a gamble?

  • GettyImages-1349092565-ERP
    Oracle NetSuite ERP Solutions

    Are you anticipating rapid growth, getting ready for an equity event, or coming off a legacy system? NetSuite ERP’s all-in-one cloud business management solution helps future-proof your organization, eliminate redundancies and data silos, and automate manual processes, so you’re always ready for your next business milestone.

  • GettyImages-849207658 Drug toxicity concept
    NDA Submissions 505(b)(1) Or 505(b)(2)

    There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough understanding of sections 505(b)(1) and 505(b)(2) of the Federal Food, Drug, and Cosmetics (FD&C) Act.

WHITE PAPERS AND CASE STUDIES

NEWS